Financial Disclosure
| Name | Panel Status | Company | Relationship |
|---|---|---|---|
| Abrams, Elaine J. | M | None | N/A |
| Anderson, Jean | M | Gilead | Stockholder |
| Badell, Martina L. | M | None | N/A |
| Best, Brookie M. | M | PPD | DSMB |
| C&R Research, Inc. | DSMB | ||
| Boucoiran, Isabelle | ExOM | Moderna, Altona, Ferring | Research Support |
| Brooks Kristina M. | M | ViiV | Consultant |
| Campbell, Danielle | M | None | N/A |
| Chakhtoura, Nahida | ES | None | N/A |
| Chakraborty, Rana | M | None | N/A |
| Chevalier, Michelle | HHS | None | N/A |
| Ciaranello, Andrea | CC | None | N/A |
| Cohn, Susan E. | M | None | N/A |
| Cu-Uvin, Susan | M | AIDS Malignancy Consortium | DSMB |
| UpToDate | Section Writer | ||
| Royalties | |||
| Flynn, Patricia M. | M | Merck | Safety Monitoring Committee |
| UpToDate | Author | ||
| Jao, Jennifer | M | None | N/A |
| Kakkar, Fatima | ExOM | None | N/A |
| Keeshin, Susana | M | None | N/A |
| Kourtis, Athena, P. | HHS | None | N/A |
| Lazenby, Gweneth B. | M | None | N/A |
| Levison, Judy | M | None | N/A |
| Matthews, Lynn | M | Gilead | Research Support |
| Mirochnick, Mark | CC | ViiV | Research Support |
| AstraZeneca | DSMB | ||
| Merck | Research Support | ||
| Gilead | Research Support | ||
| Mofenson, Lynne M. | M | None | N/A |
| Momplaisir, Florance | M | None | N/A |
| Nesheim, Steve | HHS | None | N/A |
| O’Connor Heather | M | None | N/A |
| Pollock, Lealah | ExOM | None | N/A |
| Powell, Anna | M | UpToDate | Author |
| Prioleau, Fatima Y. | M | None | N/A |
| Rahangdale, Lisa | M | None | N/A |
| Rosebush Julia | M | None | N/A |
| Scott, Rachel K. | M | ViiV | Research Support |
| GSK | Research Support | ||
| Gilead | Research Support | ||
| Sheffield, Jeanne | M | None | N/A |
| Sheth Anandi | M | None | N/A |
| Short, William R. | M | ViiV | Consultant |
| Janssen | Consultant | ||
| Siberry, George K. | M | None | N/A |
| Sissoho, Fatoumatta | M | None | N/A |
| Spector, Stephen A. | M | J&J | Stockholder |
| Storm, Deborah | C | Merck | Stockholder |
| Eli Lilly and Company | Stockholder | ||
| Roche | Stockholder | ||
| Viswanathan, Prabha | HHS | None | N/A |
| Wilcox, Ronald | HHS | None | N/A |
| Wright, Rodney L. | M | None | N/A |
| Yee, Lynn M. | M | None | N/A |
| Zash, Rebecca | M | None | N/A |
| Key: DSMB = Data Safety Monitoring Board; C=Consultant; CC = Panel Co-Chairs; ES = Executive Secretary; ExOM = Ex Officio Member; HHS = Member from Department of Health and Human Services; M = Member; N/A = Not applicable | |||
Download Guidelines
- Section Only PDF (129.79 KB)|spaceless
- Full Guideline PDF (6.28 MB)|spaceless
- Recommendations Only PDF (459.99 KB)|spaceless
- Tables Only PDF (907.8 KB)|spaceless